Upcoming Workshops
For All Cancers
For Gastrointestinal Stromal Tumors
For Liver Cancer
Past workshops
For All Cancers
- Understanding Diagnostic Technologies and Biomarkers
- Clinical Trials: How They Transform the Treatment of Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- CAR T-Cell Therapy: What's New
- Clinical Trials: How They Transform the Treatment of Cancer
- What’s New in Precision Medicine
- What’s New in Diagnostic Technologies for People Living with Solid Cancer TumorsPart I of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- How Diagnostic Technologies and Biomarkers Improve Treatment Decisions for People Living with Cancer
- Understanding Diagnostic Technologies and Biomarkers
For Acute Lymphoblastic Leukemia
For Acute Myeloid Leukemia
For Bladder Cancer
For Breast Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Metastatic Breast Cancer: Treatment Updates
- The Role of Radiation Therapy in the Treatment of Breast Cancer
- Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
- Metastatic Breast Cancer: Treatment Updates
For Chronic Lymphocytic Leukemia
For Chronic Myelogenous Leukemia
For Colorectal Cancer
For Cutaneous T-Cell Lymphoma
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Update on CAR T-Cell Therapies
For Diffuse Large B-Cell Lymphoma
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Update on CAR T-Cell Therapies
For Endometrial Cancer
For Follicular Lymphoma
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Update on CAR T-Cell Therapies
For Gastric Cancer
For Gastrointestinal Stromal Tumors
For Head and Neck Cancer
For Hodgkin Lymphoma
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Update on CAR T-Cell Therapies
For Leukemia
For Liver Cancer
For Lung Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Non-Small Cell Lung Cancer: Biomarker Testing & Treatment TrendsPart II of Living with Non-Small Cell Lung Cancer
- Non-Small Cell Lung Cancer: What's NewPart I of Living with Non-Small Cell Lung Cancer
- What’s New in Diagnostic Technologies for People Living with Small Cell Lung CancerPart II of Living with Small Cell Lung Cancer
- Genomic Testing and Current Trends in the Treatment of Non-Small Cell Lung CancerPart III of Living with Non-Small Cell Lung Cancer
- Small Cell Lung Cancer: Treatment UpdatePart I of Living with Small Cell Lung Cancer
- Non-Small Cell Lung Cancer: Genomic Testing & Current Treatment TrendsPart II of Living with Non-Small Cell Lung Cancer
- Genomic Testing & Current Trends in the Treatment of Non-Small Cell Lung CancerPart II of Living with Lung Cancer
For Lymphoma
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Update on CAR T-Cell Therapies
For Mantle Cell Lymphoma
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Update on CAR T-Cell Therapies
For Marginal Zone Lymphoma
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Update on CAR T-Cell Therapies
For Melanoma
For Mesothelioma
For Metastatic Breast Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Metastatic Breast Cancer: Treatment Updates
- The Role of Radiation Therapy in the Treatment of Breast Cancer
- Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
- Metastatic Breast Cancer: Treatment Updates
For Multiple Myeloma
For Myelodysplastic Syndromes
For Myelofibrosis
For Myeloproliferative Neoplasms
For Non-Hodgkin Lymphoma
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Update on CAR T-Cell Therapies
For Ovarian Cancer
For Peripheral T-Cell Lymphoma
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Update on CAR T-Cell Therapies
For Polycythemia Vera
For Small Lymphocytic Lymphoma
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Update on CAR T-Cell Therapies
For Stomach Cancer
For Triple Negative Breast Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Metastatic Breast Cancer: Treatment Updates
- The Role of Radiation Therapy in the Treatment of Breast Cancer
- Metastatic Breast Cancer: Treatment Updates